Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,833 | 219 | 50.1% |
| Consulting Fee | $3,500 | 1 | 36.2% |
| Travel and Lodging | $1,202 | 3 | 12.4% |
| Education | $121.36 | 3 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $5,506 | 34 | $0 (2024) |
| ABBVIE INC. | $1,489 | 56 | $0 (2024) |
| LEO Pharma Inc. | $905.92 | 60 | $0 (2024) |
| Amgen Inc. | $659.25 | 39 | $0 (2020) |
| Janssen Biotech, Inc. | $347.15 | 13 | $0 (2024) |
| Lilly USA, LLC | $170.53 | 7 | $0 (2023) |
| Sun Pharmaceutical Industries Inc. | $125.80 | 4 | $0 (2022) |
| Galderma Laboratories, L.P. | $113.38 | 1 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $110.15 | 4 | $0 (2021) |
| Janssen Scientific Affairs, LLC | $81.07 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $957.99 | 56 | LEO Pharma Inc. ($607.83) |
| 2023 | $485.40 | 25 | PFIZER INC. ($271.31) |
| 2022 | $403.86 | 21 | ABBVIE INC. ($131.62) |
| 2021 | $315.40 | 14 | Lilly USA, LLC ($95.30) |
| 2020 | $350.88 | 15 | AbbVie Inc. ($194.72) |
| 2019 | $470.51 | 26 | Amgen Inc. ($241.64) |
| 2018 | $779.98 | 41 | AbbVie, Inc. ($236.66) |
| 2017 | $5,892 | 28 | PFIZER INC. ($5,085) |
All Payment Transactions
226 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: DERMATOLOGY | ||||||
| 12/12/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: DERMATOLOGY | ||||||
| 12/06/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: DERMATOLOGY | ||||||
| 11/25/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: DERMATOLOGY | ||||||
| 11/21/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: DERMATOLOGY | ||||||
| 11/20/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: DERMATOLOGY | ||||||
| 11/19/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $28.66 | General |
| Category: DERMATOLOGY | ||||||
| 11/14/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: DERMATOLOGY | ||||||
| 11/12/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: DERMATOLOGY | ||||||
| 11/07/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: DERMATOLOGY | ||||||
| 11/04/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: DERMATOLOGY | ||||||
| 10/31/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: DERMATOLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $32.88 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: DERMATOLOGY | ||||||
| 10/17/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: DERMATOLOGY | ||||||
| 10/10/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: DERMATOLOGY | ||||||
| 10/03/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: DERMATOLOGY | ||||||
| 09/26/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: DERMATOLOGY | ||||||
| 09/19/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: DERMATOLOGY | ||||||
| 09/12/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: DERMATOLOGY | ||||||
| 09/05/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: DERMATOLOGY | ||||||
| 08/29/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: DERMATOLOGY | ||||||
| 08/22/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $10.69 | General |
| Category: DERMATOLOGY | ||||||
| 08/15/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $10.69 | General |
| Category: DERMATOLOGY | ||||||
| 08/08/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,293 | 9,270 | $402,806 | $181,396 |
| 2022 | 9 | 1,059 | 8,635 | $394,623 | $179,863 |
| 2021 | 8 | 863 | 8,225 | $380,354 | $179,297 |
| 2020 | 8 | 798 | 7,444 | $304,767 | $135,229 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 262 | 7,425 | $111,375 | $51,001 | 45.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 323 | 666 | $109,890 | $50,530 | 46.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 277 | 623 | $80,990 | $35,839 | 44.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 233 | 233 | $47,765 | $19,172 | 40.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 57 | 82 | $18,450 | $8,878 | 48.1% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 30 | 55 | $14,575 | $6,873 | 47.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 56 | 62 | $13,020 | $6,074 | 46.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 15 | $3,525 | $1,794 | 50.9% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 17 | 27 | $2,970 | $1,166 | 39.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 24 | 82 | $246.00 | $68.70 | 27.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 279 | 732 | $120,780 | $57,296 | 47.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 202 | 6,776 | $101,640 | $46,311 | 45.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 206 | 554 | $72,020 | $32,166 | 44.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 170 | 170 | $34,850 | $13,975 | 40.1% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2022 | 49 | 100 | $26,500 | $12,888 | 48.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 65 | 101 | $22,725 | $10,427 | 45.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 52 | 63 | $13,230 | $5,934 | 44.9% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2022 | 12 | 23 | $2,530 | $762.99 | 30.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 24 | 116 | $348.00 | $103.46 | 29.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 261 | 831 | $129,945 | $65,391 | 50.3% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 163 | 6,389 | $95,835 | $42,974 | 44.8% |
| 17000 | Destruction of skin growth | Office | 2021 | 170 | 556 | $70,630 | $31,479 | 44.6% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 53 | 120 | $26,720 | $13,640 | 51.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 130 | 130 | $26,310 | $10,751 | 40.9% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 47 | 88 | $18,080 | $8,669 | 47.9% |
About Dr. Ernest Bloom, MD
Dr. Ernest Bloom, MD is a Dermatology healthcare provider based in Alameda, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306941620.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ernest Bloom, MD has received a total of $9,656 in payments from pharmaceutical and medical device companies, with $957.99 received in 2024. These payments were reported across 226 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($4,833).
As a Medicare-enrolled provider, Bloom has provided services to 4,013 Medicare beneficiaries, totaling 33,574 services with total Medicare billing of $675,786. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Other Specialties MOHS-Micrographic Surgery, Dermatopathology
- Location Alameda, CA
- Active Since 09/13/2006
- Last Updated 01/31/2013
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1306941620
Products in Payments
- EUCRISA (Drug) $5,317
- Enbrel (Biological) $659.25
- Humira (Biological) $639.29
- ADBRY (Biological) $607.83
- SKYRIZI (Biological) $565.69
- ENSTILAR (Drug) $210.55
- TREMFYA (Drug) $200.63
- CIBINQO (Drug) $188.85
- TALTZ (Drug) $170.53
- DUPIXENT (Biological) $140.85
- Tremfya (Drug) $96.07
- PICATO (Drug) $87.54
- REMICADE (Biological) $77.31
- HUMIRA (Biological) $71.91
- ILUMYA (Biological) $62.08
- VTAMA (Drug) $52.95
- RINVOQ (Biological) $51.05
- Winlevi (Drug) $39.02
- Skyrizi (Biological) $36.18
- STELARA (Biological) $28.38
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.